Work

Yttrium-90 Microsphere Radioembolization for Treatment of Lung Cancer Hepatic Metastases

Year: 2012

Type: article

Abstract: Because stage 4 lung cancer is associated with dismal 5-year survival rates, new treatment approaches targeting extrapulmonary disease are necessary. Yttrium-90 microsphere radioembolization is an emerging treatment for metastatic hepatic malignancies that results in high tumor response rates and extended patient survival. To date, application of this therapy toward management of lung cancer hepatic metastases has not been extensively described. Herein, we present 2 cases of effective yttrium-90 radioembolization for treatment of lung cancer hepatic metastases, and emphasize the potential coadjuvant value of this procedure in patients with advanced-stage lung cancer and liver-dominant metastatic disease.

Source: Case Reports in Oncology

DOI: 10.1159/000342706

Authors: Ron C. Gaba, Janesh Lakhoo

Institutions: University of Illinois Hospital & Health Sciences System, University of Illinois Chicago

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,170